# Top 15 Life Science Startup Investors in Singapore in May 2026

## EDBI
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 3
- Stages: Series C, Series B, Series D
- Focus: Biotechnology, Software, Health Care

EDBI is a premier Asian investor with headquarters in Singapore.

## Anzu Partners
- Type: VC Fund
- Location: Washington, District of Columbia, United States
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Biotechnology, Manufacturing, Software

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

## Eisai
- Type: VC Fund
- Location: Tokyo, Tokyo, Japan
- Relevant deals: 2
- Stages: Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

## Lightstone Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

## KB Financial Group
- Type: VC Fund
- Location: Seoul, Seoul-t'ukpyolsi, South Korea
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Financial Services, Software, SaaS

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

## Amgen Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

## Hana Financial Investment
- Type: VC Fund
- Location: Seoul, Seoul-t'ukpyolsi, South Korea
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Information Technology, Biotechnology, Health Care

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

## M Capital Partners
- Type: VC Fund
- Location: Toulouse, Midi-Pyrenees, France
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Food and Beverage, Software

M Capital is an independent investment company with +€500m AuM.
A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth.
In 2020, M Capital has funded over 200 French companies.

## KT investment
- Type: VC Fund
- Location: Seoul, Seoul-t'ukpyolsi, South Korea
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Artificial Intelligence, Software, Information Technology

kt investment is a new technology business finance company established in 2015. It is an investment company that represents KT Group .kt investment seeks to contribute to social contribution and maximize investment return through win-win cooperation with promising SMEs and venture companies .kt investment seeks to achieve long-term returns bylooking at the market from a global perspective and looking for value investment opportunities in the long term.

## K3 Ventures
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Financial Services, FinTech, Software

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

## Openspace
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: E-Commerce, Financial Services, Information Technology

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

## Nestlé
- Type: VC Fund
- Location: Vevey, Vaud, Switzerland
- Relevant deals: 1
- Stages: Private Equity, Grant
- Focus: Food and Beverage, Health Care, Therapeutics

Nestlé manufactures and sells food and beverage for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestlé, Nescafé, Perrier, Pure Life, and Purina. Nestlé also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

## Seeds Capital
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Health Care, Biotechnology

Seeds Capital is an investment arm of Enterprise Singapore that co-invests with independent investors in innovative startups. The firm was founded in 1992 and is headquartered in Central Region, Singapore.

## Temasek Holdings
- Type: VC Fund
- Location: Singapore, Central Region, Singapore
- Relevant deals: 1
- Stages: Series B, Series C, Series D
- Focus: Biotechnology, Health Care, Software

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 900 people. Our portfolio is valued at S$403 billion.

## SK Securities
- Type: VC Fund
- Location: Yongdungpo, Seoul-t'ukpyolsi, South Korea
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Therapeutics, Apps, Biotechnology

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co